{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:03:01Z","timestamp":1790722981990,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T00:00:00Z","timestamp":1130889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1038\/sj.npp.1300950","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T19:51:04Z","timestamp":1132170664000},"page":"1264-1273","source":"Crossref","is-referenced-by-count":88,"title":["Neurochemical Effects of Olanzapine in First-Hospitalization Manic Adolescents: A Proton Magnetic Resonance Spectroscopy Study"],"prefix":"10.1038","volume":"31","author":[{"given":"Melissa P","family":"DelBello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb M","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Strakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,2]]},"reference":[{"key":"BF1300950_CR1","unstructured":"AIMS (1976). ECDEU Assessment Manual for Psychopharmacology (revised edition) US Department of Health, Education and Welfare: Rockville, Maryland."},{"key":"BF1300950_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TRE Barnes","year":"1989","unstructured":"Barnes TRE (1989). A rating scale for drug induced akathisia. Br J Psychiatry 154: 672\u2013676.","journal-title":"Br J Psychiatry"},{"key":"BF1300950_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1006\/bbrc.1996.0008","volume":"218","author":"TE Bates","year":"1996","unstructured":"Bates TE, Loesch A, Burnstock G, Clark JB (1996). Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218: 40\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1300950_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/104454603322724904","volume":"13","author":"RK Bhangoo","year":"2003","unstructured":"Bhangoo RK, Lowe CH, Myers FS, Treland J, Curran J, Towbin KE et al (2003). Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 13: 515\u2013522.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF1300950_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1196\/annals.1308.048","volume":"1021","author":"HP Blumberg","year":"2004","unstructured":"Blumberg HP, Kaufman J, Martin A, Charney DS, Krystal JH, Peterson BS (2004). Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Ann N Y Acad Sci 1021: 376\u2013383.","journal-title":"Ann N Y Acad Sci"},{"key":"BF1300950_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S1461145703003419","volume":"6","author":"N Brunello","year":"2003","unstructured":"Brunello N, Tascedda F (2003). Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol 6: 181\u2013189.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BF1300950_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1038\/sj.mp.4001019","volume":"7","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Felder CC (2002). Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Mol Psychiatry 7: S57\u2013S63.","journal-title":"Mol Psychiatry"},{"key":"BF1300950_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.pnpbp.2003.09.008","volume":"27","author":"FP Bymaster","year":"2003","unstructured":"Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL (2003). Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27: 1125\u20131143.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300950_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1034\/j.1399-5618.2002.02235.x","volume":"4","author":"KM Cecil","year":"2002","unstructured":"Cecil KM, DelBello MP, Morey R, Strakowski SM (2002). Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4: 357\u2013365.","journal-title":"Bipolar Disord"},{"key":"BF1300950_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/104454603322724931","volume":"13","author":"KM Cecil","year":"2003","unstructured":"Cecil KM, DelBello MP, Sellars MC, Strakowski SM (2003). Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 13: 545\u2013555.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF1300950_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0006-3223(02)01744-4","volume":"53","author":"K Chang","year":"2003","unstructured":"Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 53: 1059\u20131065.","journal-title":"Biol Psychiatry"},{"key":"BF1300950_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archpsyc.61.8.781","volume":"61","author":"K Chang","year":"2004","unstructured":"Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A (2004). Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61: 781\u2013792.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300950_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/cap.2000.10.45","volume":"10","author":"KD Chang","year":"2000","unstructured":"Chang KD, Ketter TA (2000). Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 10: 45\u201349.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF1300950_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61: 450\u2013458.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300950_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0893-133X(00)00207-4","volume":"24","author":"P Davanzo","year":"2001","unstructured":"Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M et al (2001). Decreased anterior cingulate myo-inositol\/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24: 359\u2013369.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300950_CR16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","volume":"41","author":"MP DelBello","year":"2002","unstructured":"DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41: 1216\u20131223.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1300950_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257\u2013269.","journal-title":"Cell"},{"key":"BF1300950_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","volume":"44","author":"RL Findling","year":"2005","unstructured":"Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD et al (2005). Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44: 409\u2013417.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1300950_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/10445460152595568","volume":"11","author":"JA Frazier","year":"2001","unstructured":"Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V et al (2001). A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11: 239\u2013250.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF1300950_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00004583-199203000-00011","volume":"31","author":"MA Fristad","year":"1992","unstructured":"Fristad MA, Weller EB, Weller RA (1992). The Mania Rating Scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 31: 252\u2013257.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1300950_CR21","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1176\/appi.ajp.161.9.1698","volume":"161","author":"B Geller","year":"2004","unstructured":"Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook Jr EH (2004). Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161: 1698\u20131700.","journal-title":"Am J Psychiatry"},{"key":"BF1300950_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00004583-200104000-00014","volume":"40","author":"B Geller","year":"2001","unstructured":"Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP et al (2001). Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 40: 450\u2013455.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1300950_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0304-3940(03)00828-0","volume":"349","author":"CJ Hong","year":"2003","unstructured":"Hong CJ, Yu YW, Lin CH, Tsai SJ (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349: 206\u2013208.","journal-title":"Neurosci Lett"},{"key":"BF1300950_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","volume":"26","author":"J Ichikawa","year":"2002","unstructured":"Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26: 325\u2013339.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300950_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/(SICI)1522-2594(200003)43:3<355::AID-MRM6>3.0.CO;2-R","volume":"43","author":"DM Lindquist","year":"2000","unstructured":"Lindquist DM, Hawk RM, Karson CN, Komoroski RA (2000). Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magn Reson Med 43: 355\u2013358.","journal-title":"Magn Reson Med"},{"key":"BF1300950_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0165-0327(94)90104-X","volume":"31","author":"JD Lish","year":"1994","unstructured":"Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM (1994). The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 31: 281\u2013294.","journal-title":"J Affect Disord"},{"key":"BF1300950_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1034\/j.1399-5618.2003.00041.x","volume":"5","author":"IK Lyoo","year":"2003","unstructured":"Lyoo IK, Demopulos CM, Hirashima F, Ahn KH, Renshaw PF (2003). Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. Bipolar Disord 5: 300\u2013306.","journal-title":"Bipolar Disord"},{"key":"BF1300950_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4088\/JCP.v61n0403","volume":"61","author":"BJ McConville","year":"2000","unstructured":"McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO et al (2000). Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 61: 252\u2013260.","journal-title":"J Clin Psychiatry"},{"key":"BF1300950_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3223(00)00252-3","volume":"48","author":"GJ Moore","year":"2000","unstructured":"Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB et al (2000a). Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48: 1\u20138.","journal-title":"Biol Psychiatry"},{"key":"BF1300950_CR30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1176\/ajp.156.12.1902","volume":"156","author":"GJ Moore","year":"1999","unstructured":"Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J et al (1999). Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156: 1902\u20131908.","journal-title":"Am J Psychiatry"},{"key":"BF1300950_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(00)02793-8","volume":"356","author":"GJ Moore","year":"2000","unstructured":"Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Menji HK (2000b). Lithium-induced increase in human brain grey matter. Lancet 356: 1241\u20131242.","journal-title":"Lancet"},{"key":"BF1300950_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02088471","volume":"9","author":"N Morris","year":"1980","unstructured":"Morris N (1980). Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc Dev 9: 271\u2013280.","journal-title":"J Youth Adolesc Dev"},{"key":"BF1300950_CR33","unstructured":"National Institute of Mental Health (1985). CGI (Clinical Global Impressions) Scale. Psychopharmacol Bull 21: 839\u2013843."},{"key":"BF1300950_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0920-9964(02)00434-6","volume":"60","author":"V Parikh","year":"2003","unstructured":"Parikh V, Evans DR, Khan MM, Mahadik SP (2003). Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome. Schizophr Res 60: 117\u2013123.","journal-title":"Schizophr Res"},{"key":"BF1300950_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jpsychires.2004.03.008","volume":"38","author":"V Parikh","year":"2004","unstructured":"Parikh V, Khan MM, Terry A, Mahadik SP (2004a). Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats. J Psychiatr Res 38: 521\u2013529.","journal-title":"J Psychiatr Res"},{"key":"BF1300950_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00213-003-1669-6","volume":"172","author":"V Parikh","year":"2004","unstructured":"Parikh V, Terry AV, Khan MM, Mahadik SP (2004b). Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine. Psychopharmacology (Berl) 172: 365\u2013374.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300950_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1399-5618.2005.00204.x","volume":"7","author":"MN Pavuluri","year":"2005","unstructured":"Pavuluri MN, Henry DB, Carbray JA, Naylor MW, Janicak PG (2005). Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 7: 266\u2013273.","journal-title":"Bipolar Disord"},{"key":"BF1300950_CR38","first-page":"979","volume":"21","author":"EO Poznanski","year":"1985","unstructured":"Poznanski EO, Freeman LN, Mokros HBR (1985). Children's Depression Rating Scale\u2014revised. Psychopharmacol Bull 21: 979\u2013989.","journal-title":"Psychopharmacol Bull"},{"key":"BF1300950_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672\u2013679.","journal-title":"Magn Reson Med"},{"key":"BF1300950_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW (2001). Automatic quantitation of localized in vivo 1H spectra with LC Model. NMR Biomed 14: 260\u2013264.","journal-title":"NMR Biomed"},{"key":"BF1300950_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0893-133X(99)00162-1","volume":"23","author":"TJ Raedler","year":"2000","unstructured":"Raedler TJ, Knable MB, Jones DW, Lafargue T, Urbina RA, Egan MF et al (2000). In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia. Neuropsychopharmacology 23: 56\u201368.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300950_CR42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1046\/j.1399-5618.2003.00071.x","volume":"5","author":"JK Rybakowski","year":"2003","unstructured":"Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J (2003). Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5: 468\u2013472.","journal-title":"Bipolar Disord"},{"key":"BF1300950_CR43","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","volume":"40","author":"D Schaffer","year":"1983","unstructured":"Schaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983). A Children's Global Assessment Scale. Arch Gen Psychiatry 40: 1228\u20131231.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300950_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00004850-200303000-00002","volume":"18","author":"PH Silverstone","year":"2003","unstructured":"Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC (2003). Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 18: 73\u201379.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1300950_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11\u201319.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"BF1300950_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-3223(95)00423-8","volume":"40","author":"AL Stoll","year":"1996","unstructured":"Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF (1996). Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 40: 382\u2013388.","journal-title":"Biol Psychiatry"},{"key":"BF1300950_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0165-0327(98)00119-0","volume":"53","author":"CA Soutullo","year":"1999","unstructured":"Soutullo CA, Sorter MT, Foster KD, McElroy SL, Keck PE (1999). Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 53: 279\u2013283.","journal-title":"J Affect Disord"},{"key":"BF1300950_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0006-3223(91)90216-9","volume":"29","author":"AL Stoll","year":"1991","unstructured":"Stoll AL, Cohen BM, Hanin I (1991). Erythrocyte choline concentrations in psychiatric disorders. Biol Psychiatry 29: 309\u2013321.","journal-title":"Biol Psychiatry"},{"key":"BF1300950_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.mp.4001585","volume":"10","author":"SM Strakowski","year":"2005","unstructured":"Strakowski SM, DelBello MP, Adler CM (2005). The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 10: 105\u2013116.","journal-title":"Mol Psychiatry"},{"key":"BF1300950_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1523\/JNEUROSCI.13-03-00981.1993","volume":"13","author":"J Urenjak","year":"1993","unstructured":"Urenjak J, Williams SR, Gadian DG, Noble M (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981\u2013989.","journal-title":"J Neurosci"},{"key":"BF1300950_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429\u2013435.","journal-title":"Br J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300950","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T21:40:49Z","timestamp":1706737249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,2]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF1300950"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300950","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,2]]}}}